Surveys show that the public are optimistic about genome editing for curing diseases, but there can also be a lack of trust about how this technology will be used.
Top researchers at Memorial Sloan Kettering Cancer Center have filed at least six corrections with medical journals recently, divulging financial relationships with health care companies that they did not previously disclose.
The Trump administration faces mounting pressure from conservative lawmakers and abortion opponents to halt the use of tissue obtained from aborted fetuses.
The center’s pathologists have objected to the deal, saying it is unfair that the founders received equity that relies on the pathologists’ expertise and work
Universities that sell access to their biobanks to private companies should tell patients and be transparent about how profits are used, a new survey shows.